To define the analgesic pharmacology of the K/BxN allodynic state, groups of 16-week-old K/BxN transgenic arthritic mice (n = 6/sex) received a single i.p. injection of gabapentin (100 mg/kg; Pfizer), or the NSAID, ketorolac (7.5 mg/kg; Sigma). Mice were measured for changes in tactile allodynia 1 h following treatment. Drugs were allowed to wash out for 48 h before the same procedure was repeated with a different drug. gabapentin50 (link),51 (link), and ketorolac24 (link) were dissolved in normal saline, dosages were based on previous reports demonstrating anti-allodynic efficacy, absent motor or general behavioral effects, in murine models of mono / poly and inflammatory neuropathy, respectively.
Free full text: Click here